T1	intervention 0 17	Nigella sativa L.
T2	condition 36 62	acute radiation dermatitis
T3	total-participants 331 340	Sixty-two
T4	eligibility 341 392	breast cancer patients undergoing radiotherapy (RT)
T5	control 446 453	placebo
T9	outcome 1198 1230	occurrence of moist desquamation
T10	outcome 1334 1362	mean score of the worst pain
T11	outcome 1584 1603	effect on the SRQOL
T8	outcome 883 914	incidence time of grade 2 and 3
T12	iv-cont-mean 1111 1113	35
T13	cv-cont-mean 1118 1125	29 days
T14	iv-cont-mean 1140 1142	42
T15	cv-cont-mean 1147 1154	40 days
T16	iv-cont-mean 1303 1305	37
T17	cv-cont-mean 1310 1317	33 days
T7	iv-cont-mean 1483 1487	2.5â€¯
T18	iv-cont-sd 1489 1492	0.5
T19	cv-cont-mean 1497 1500	1.2
T20	cv-cont-sd 1503 1506	0.3
